K Bollinger, J Kim, CY Lowder, PK Kaiser… - Ophthalmology, 2011 - Elsevier Retrospective review of medical records of all patients receiving FA implants between June 2001 and March 2009 was performed. Data were pooled to record visual acuity (VA) and to characterize the incidence and outcome of glaucoma surgical intervention. ... Incidence of glaucoma ... Related articles - All 2 versions
W Muincharern, P Louwakul, P Pavasant… - Journal of …, 2011 - Elsevier The goal of vital pulp therapy is to maintain pulp vitality and function. Fluocinolone acetonide is a potent topical glucocorticoid used in the treatment of skin disorders and oral lesions that could possibly be used to resolve inflammation and stimulate the healing process of ... Related articles - All 3 versions
[HTML] from ophsource.netPA Pearson, TL Comstock, M Ip, D Callanan… - Ophthalmology, 2011 - Elsevier We studied the 3-year efficacy and safety results of a 4-year study evaluating fluocinolone acetonide (FA) intravitreal implants in eyes with persistent or recurrent diabetic macular edema (DME). ... Prospective, evaluator-masked, controlled, multicenter clinical trial.
MJ Fredriksson, P Petersson, BO Axelsson… - Analytica Chimica …, 2011 - Elsevier A strategy for rapid optimization of liquid chromatography column temperature and gradient shape is presented. The optimization as such is based on the well established retention and peak width models implemented in software like eg DryLab and LC simulator. The novel part of the ...
J Hu, M Coassin… - Ocular Immunology and …, 2011 - informahealthcare.com Purpose: To report the authors' experience using fluocinolone acetonide (Retisert) to treat cystoid macular edema (CME) resulting from immune recovery uveitis (IRU) in 2 acquired immunodeficiency syndrome (AIDS) patients with a history of cytomegalovirus (CMV) retinitis. Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
